Video workouts before pancreatic surgery: a new hope?
NCT ID NCT05836870
First seen Jun 27, 2026 · Last updated Aug 13, 2026 · Updated 2 times
Summary
This study tests whether a supervised, video-based exercise program done at home during chemotherapy can help people with pancreatic cancer get stronger before surgery. About 58 patients will take part. The goal is to see if the program is safe and helps improve recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
58 people
The number who actually took part.
- Started
-
Jul 2023
- Expected to finish
-
Dec 2032
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Provision of signed and dated informed consent form * Biopsy-proven pancreatic adenocarcinoma, resectable/borderline resectable (T1-3, N0-2, M0) * Recommended to receive 2-6 months of neoadjuvant chemotherapy followed by surgical resection including participants who have not yet received chemotherapy and participants who have already received their first cycle of chemotherapy. * Willingness to adhere to the Tele-PancFit study intervention * Eastern Cooperative Oncology Group (ECOG) performance status 0-1 * Able to schedule baseline (T0) appointment for fitness testing and program teaching at the fitness testing location at each study site or able to schedule remote fitness testing and program teaching: 1. Behavioral Research and Treatment Center (BRTC) at MDACC 2. Exercise Physiology laboratory in the Department of Kinesiology and Health Education at UT Austin 3. Outpatient Rehabilitation gymnasium at Banner MDA * Able to understand the description of the study, exercise program, and willing to participate * Home or community access to wireless internet (Wi-Fi) and agreement to engage with study personnel for real-time tele-RT sessions * Age ≥ 18 * Meet all screening requirements (described below). Exclusion criteria: An individual who meets any of the following criteria will be excluded from participation in this study: * Non-English speaking * Has participated in regular RT (RT for all major muscle groups at least twice per week) throughout the month prior to recruitment * Unable to complete the baseline assessment questionnaires or functional assessments * Screen failure for exercise safety based on PAR-Q and/or PROMIS questions as described in section 4.4 (Screening Procedure). * Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease (New York Heart Association functional class III or IV). * Recent fracture or acute musculoskeletal injury that precludes the ability to weight bear fully on all 4 limbs in order to participate in an exercise intervention. * Numeric pain rating scale of ≥7 out of 10 * Myopathic or rheumatologic disease that impacts physical function. * (Females only) Known pregnancy, as communicated to study personnel by clinicians in GI Medical Oncology; females of childbearing potential receive advice to use methods of contraception per usual care.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pancreatic adenocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug combo crack pancreatic Cancer's defenses?
- Can digital questionnaires improve life during pancreatic cancer therapy?
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Can a blood test before pancreatic surgery predict a dangerous leak?
- New chemo cocktail targets pancreatic cancer at every stage
- Bacteria-Based immunotherapy targets pancreatic tumors in first human test